Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Veracyte, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services-Medical Laboratories
Prev close 40.08 · gapped above the open, then crossed back over prior close. High/low 42.06 at 9:45 am ET, 39.35 at 1:45 pm ET.
Veracyte, Inc. has 2 disclosed suppliers and 7 disclosed customers. Each one is named in an SEC filing, either Veracyte, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Each disclosed tie as a share of both companies’ annual revenue. The bigger share is the side that would feel it if the relationship ended.
| Partner | % of their revenue | % of VCYT revenue | Skew |
|---|---|---|---|
| UNHUnitedHealthcare Group | 0.02% | 13.00% | 865× |
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Third-party payers and other customers in excess of 10% of total revenue and their related revenue as a percentage of total revenue were as follows for the years presented: Year Ended December 31, 2024 2023 2022 Medicare 31 % 31 % 31 % UnitedHealthcare 13 % 11 % 11 % 44 % 42 % 42 %”
$67M relationship865× more of VCYT’s book than UNH’s
basisVCYT fy2025 · closed 2025-12 $517MUNH fy2025 · closed 2025-12 $448B
FILING10-K0001384101-25-000014cik 0001384101
“For example, we rely on NanoString (now Bruker Spatial Biology as a result of Bruker Corporation's asset acquisition of NanoString) for certain components and raw materials for the Prosigna test and nCounter service kits.”
FILING10-K0001384101-26-000010cik 0001384101
“The percentage of our revenue derived from our significant payers, such as Medicare and UnitedHealthcare Group, is expected to fluctuate from period to period as our revenue fluctuates, as additional payers provide reimbursement for our tests or if one or more payers were to stop reimbursing for our tests or change their reimbursed amounts.”
FILING10-K0001384101-25-000014cik 0001384101
“This code underwent the national payment determination process for Medicare in 2020, through which the Centers for Medicare & Medicaid Services, or CMS, set its reimbursement rate at $3,600 on the Clinical Laboratory Fee Schedule (CLFS), the same rate as the prior CPT code for Afirma GEC, unchanged since 2018.”
FILING10-K0001384101-25-000014cik 0001384101
“Additionally, Decipher Bladder was assigned CPT code 0016U, which CMS priced through the gapfill process, setting a final CLFS reimbursement rate of $3469.83 effective January 1, 2021.”
FILING10-K0001384101-26-000010cik 0001384101
“For example, coverage and payment determinations for our Afirma GSC classifier are covered by Noridian Healthcare Solutions, the current MAC for our jurisdiction, through the MolDX program, administered by Palmetto GBA, under a Local Coverage Determination, or LCD.”
FILING10-K0001384101-25-000014cik 0001384101
“Additionally, Decipher Prostate is currently reimbursed by Medicare pursuant to LCDs issued by Palmetto GBA's MolDX program and adopted by Noridian Healthcare Solutions, each acting as a MAC, as well as by a number of commercial payers.”
FILING10-K0001384101-25-000014cik 0001384101
“For example, Decipher Prostate is currently reimbursed by Medicare pursuant to LCDs issued by Palmetto GBA's MolDX program and adopted by Noridian Healthcare Solutions, each acting as a MAC, as well as by a number of commercial payers.”
FILING10-K0001384101-26-000010cik 0001384101
“In 2023, the global banking system experienced turmoil, including the closure of Silicon Valley Bank, or SVB, where we had cash and cash equivalents and short-term investments at SVB or under SVB management.”
FILING10-K0001384101-25-000014cik 0001384101
Watchlist prices, news filtered to it, and its next report on your desk.
VCYT (Veracyte, Inc.) has 2 disclosed suppliers and 7 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: BRKR +5.85%, in healthcare.